These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8614386)

  • 1. Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis.
    Henter JI; Andersson B; Elinder G; Jakobson A; Lübeck PO; Söder O
    Med Pediatr Oncol; 1996 Jul; 27(1):21-5. PubMed ID: 8614386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation?
    Honda K; Ohga S; Takada H; Nomura A; Ohshima K; Kinukawa N; Mizuno Y; Hara T
    Int J Hematol; 2000 Jul; 72(1):55-60. PubMed ID: 10979210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia.
    Schmid I; Schmitt M; Streiter M; Meilbeck R; Haas RJ; Stachel DK
    Eur J Med Res; 2005 Nov; 10(11):457-61. PubMed ID: 16354598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters.
    Hulkkonen J; Vilpo J; Vilpo L; Koski T; Hurme M
    Haematologica; 2000 Jun; 85(6):600-6. PubMed ID: 10870116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 beta and interleukin-1 receptor antagonist levels in cerebrospinal fluid of aseptic meningitis patients.
    Yokoyama T; Oda M; Seino Y
    Pediatr Allergy Immunol; 1998 May; 9(2):91-6. PubMed ID: 9677604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in Gaucher's disease.
    Barak V; Acker M; Nisman B; Kalickman I; Abrahamov A; Zimran A; Yatziv S
    Eur Cytokine Netw; 1999 Jun; 10(2):205-10. PubMed ID: 10400826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
    Higgins GC; Wu Y; Postlethwaite AE
    J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
    Barak V; Nisman B; Polliack A; Vannier E; Dinarello CA
    Eur Cytokine Netw; 1998 Mar; 9(1):33-9. PubMed ID: 9613675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease.
    Holmlund A; Hänström L; Lerner UH
    J Clin Periodontol; 2004 Jun; 31(6):475-82. PubMed ID: 15142219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable role of interleukin 10 in patients with polymyalgia rheumatica.
    Straub RH; Herfarth HH; Rinkes B; Konecna L; Glück T; von Landenberg P; Georgi J; Helmke K; Schölmerich J; Vaith P; Lang B
    J Rheumatol; 1999 Jun; 26(6):1318-25. PubMed ID: 10381050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy.
    Kumari S; Bhol KC; Rehman F; Foster CS; Ahmed AR
    Cytokine; 2001 May; 14(4):218-24. PubMed ID: 11448121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.